Clinical Trial Update: To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation [NA]

View source ↗

Summary

A completed clinical trial assessing whether a probiotic formulation benefits patients with non-alcoholic fatty liver disease and modulates gut microbiota. Spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Probiotic formulation

Snippet

Sponsor: GenMont Biotech Incorporation | Conditions: Non-Alcoholic Fatty Liver Disease | NA | Status: COMPLETED